These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 17192336

  • 1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
    Ekberg K, Brismar T, Johansson BL, Lindström P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J.
    Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
    [Abstract] [Full Text] [Related]

  • 2. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.
    Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ, MBBQ Study Group.
    Clin Ther; 2005 Aug; 27(8):1164-80. PubMed ID: 16199243
    [Abstract] [Full Text] [Related]

  • 3. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
    Brooks B, Delaney-Robinson C, Molyneaux L, Yue DK.
    J Diabetes Complications; 2008 Aug; 22(2):88-95. PubMed ID: 18280438
    [Abstract] [Full Text] [Related]

  • 4. Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes.
    Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindström P, Wahren J.
    Diabetes; 2003 Feb; 52(2):536-41. PubMed ID: 12540632
    [Abstract] [Full Text] [Related]

  • 5. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
    Zhang W, Kamiya H, Ekberg K, Wahren J, Sima AA.
    Diabetes Metab Res Rev; 2007 Jan; 23(1):63-70. PubMed ID: 16845685
    [Abstract] [Full Text] [Related]

  • 6. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G, Bastyr EJ, Wolka AM, Vinik AI.
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.
    Turgut N, Karasalihoglu S, Kücükugurluoglu Y, Balci K, Ekuklu G, Tütüncüler F.
    Clin Neurophysiol; 2004 Jun; 115(6):1452-6. PubMed ID: 15134714
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diabetic neuropathy in patients with "latent autoimmune diabetes of the adults" (LADA) compared with patients with type 1 and type 2 diabetes.
    Baum P, Hermann W, Verlohren HJ, Wagner A, Lohmann T, Grahmann F.
    J Neurol; 2003 Jun; 250(6):682-7. PubMed ID: 12796829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
    Karsidag S, Morali S, Sargin M, Salman S, Karsidag K, Us O.
    Diabetes Res Clin Pract; 2005 Mar; 67(3):211-9. PubMed ID: 15713353
    [Abstract] [Full Text] [Related]

  • 15. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
    Tesfaye S, Tandan R, Bastyr EJ, Kles KA, Skljarevski V, Price KL, Ruboxistaurin Study Group.
    Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
    [Abstract] [Full Text] [Related]

  • 16. Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients.
    Uluc K, Isak B, Borucu D, Temucin CM, Cetinkaya Y, Koytak PK, Tanridag T, Us O.
    Clin Neurophysiol; 2008 Apr; 119(4):880-5. PubMed ID: 18291716
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
    Kamiya H, Zhang W, Ekberg K, Wahren J, Sima AA.
    Diabetes; 2006 Dec; 55(12):3581-7. PubMed ID: 17130507
    [Abstract] [Full Text] [Related]

  • 20. Long-term effects of pancreatic transplantation on diabetic neuropathy.
    Navarro X, Sutherland DE, Kennedy WR.
    Ann Neurol; 1997 Nov; 42(5):727-36. PubMed ID: 9392572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.